Always ask a doctor before trying a new supplement particularly if you have health conditions
Using prescription data, we evaluated both overall prescribing rates across all GLP-1s, with a focus on AOM tirzepatide and AOM semaglutide
Immunohistochemistry and confocal microscopy studies showed distinctive staining of neurofilaments around iNOS in the cytoplasm of neurons, particularly in brain tissues from alcohol ingestion (Fig
If you'd like more personalized support, I offer one-on-one consultations to help you navigate your weight loss journey successfully
Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
Previously, BPC 157 as an originally anti-ulcer peptide was implemented in inflammatory bowel disease trials [1015], and now multiple sclerosis [16], lethal dose (LD1) could be not achieved [1016]
.png)
